Translation of "Bisherige therapie" in English

The therapy with vitamins and massages used up until now was largely unsuccessful.

The course under treatment seems similar so far .

Special consideration should be given to the antiretroviral treatment history and the resistance profile of the HIV strain of the mother.

Special consideration should be given to the antiretroviral treatment history and the resistance profile of the HIV strain of the mother.

It is also used in patients who experienced serious side effects with previous treatment and are not able to continue taking it.

Tasigna is used in patients with CML who are no longer benefiting from previous treatment including imatinib.

It is also used in adult and paediatric patients who experienced serious side effects with previous treatment and are not able to continue taking it.

Patients either changed to Atripla (N=203) or continued on their original antiretroviral treatment regimen (N=97).

Patients either changed to efavirenz/emtricitabine/tenofovir disoproxil (N=203) or continued on their original antiretroviral treatment regimen (N=97).

Tasigna is used in adult and paediatric patients with newly diagnosed CML or in patients with CML who are no longer benefiting from previous treatment including imatinib.

The current therapy for ulcerative colitis principally comprises administering anti-inflammatory substances such as 5-aminosalicylic acid or antibiotics/chemotherapeutics such as metronidazole or some sulfonamide derivatives.

Hemlibra demonstrated superior efficacy compared to prior treatment with bypassing agents in two phase III studies in adults, adolescents and children.

Patients two to 17 years of age with active sJIA for at least six months (average disease duration in the study was five years) who could not tolerate, or did not respond well to their current therapy (NSAIDs and systemic corticosteroids) were randomized to receive ACTEMRA (8 mg/kg if weight =30 kg or 12 mg/kg if weight < 30 kg) or placebo every two weeks as a 60-minute single intravenous drip infusion for a total of 12 weeks.

Even if it turns out that your complaints result from progression of CF-lung disease, it has to be evaluated whether your past therapy can be further extended or optimized.

Patients two to 17 years of age with active SJIA for at least six months (average disease duration in the study was five years) who could not tolerate, or did not respond well to their current therapy (NSAIDs and systemic corticosteroids) were randomized to receive Actemra (8 mg/kg if weight ?30 kg or 12 mg/kg if weight < 30 kg) or placebo every two weeks as a 60-minute single intravenous drip infusion for a total of 12 weeks.

In the Munich data set an extensive parameter collection documenting the ophthalmological status is stored (visual acuity, anterior segment exam, fundus lesions, complications of advanced disease, previous therapy).

In addition to a detailed anamnesis and a physical examination, the previous diagnostics and therapy are reviewed and discussed.

The alcoholic is regarded as a diseased person according to this modern set of values even if hitherto therapy has still not been able to achieve a breakthrough.

The new dose of 10mg of rivaroxaban once a day is to supplement the current therapy of 20mg once a day and is intended for use as an anticoagulation therapy to reduce the risk of recurrent venous thromboembolism after at least six months of standard therapy with anticoagulants.

Normally, Melanie would now be impatient but the current treatment has led to her being very patient waiting to get started.

For each contact form, the following information is required for a smooth process of the request: current diagnosis or illness, previous therapy and last treatments, diagnoses or findings (which you can upload), first name, last name, gender, telephone number, email, place of residence, type of insurance, and request for appointment (for diagnosis and examination, surgery, or a second opinion). This is also transmitted to the doctor to make an appointment.

This fact explains the predominant failure of cancer prevention and therapy up until now.

This fact explains the relative failure of the previous attempts at cancer prevention and therapy.

If possible we need all your test results as well as a summary of any previous treatments and doses.

The new therapy is further tested and judged and is compared to present therapies.

Forty-eight week data showed that high levels of virologic suppression, comparable to the original treatment regimen, were maintained in patients who were randomised to change to Atripla (see Table 4).

27 week data showed that high levels of virologic suppression, comparable to the original treatment regimen, were maintained in patients who were randomised to change to Atripla (see Table 6).

When switching patients from another DMT to TYSABRI, the half-life and mode of action of the other therapy must be considered in order to avoid an additive immune effect whilst at the same time minimising the risk of disease reactivation.

Forty-eight week data showed that high levels of virologic suppression, comparable to the original treatment regimen, were maintained in patients who were randomised to change to efavirenz/emtricitabine/tenofovir disoproxil (see Table 4).